Site is Being Upgraded

Cardiomyopathy

November 30, 2018

Steroid-based therapy for Cardiomyopathy:  Prostaglandin E2 (PGE2)/Dinoprostone (Trade name: PGE2, Cervidil, Propess, others) decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via upregulation of its target gene, 30/November/2018,  7.10 pm

Introduction: What they say A recent study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]
November 30, 2018

A probiotic way to keep the cardiac diseases at bay: Probiotic Lactobacillus reuteri-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients:  Probiotic Lactobacillus reuteri increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down-regulation of its target gene, 30/November/2018, 9.58 am

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]
November 28, 2018

Hot-water immersion therapy may safeguard your heart against cardiac dysfunction: Hot-water immersion therapy ( at 39°C for 1 hour) for cardiomyocyte proliferation and heart regeneration: Hot-water immersion therapy decreases tumor suppressor Mir-128 and cyclin-dependent kinase inhibitor p27 expression, increases SUZ12 expression, increases Cyclin E and CDK2 expression, promotes proliferation/re-entry of postnatal/adult cardiomyocytes, attenuates fibrosis, ameliorates cardiac dysfunction, and promotes heart repair in response to myocardial infarction, via up-regulation of its target gene, 28/September/2018, 12.13 am

Introduction: What they say: A recent study from Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA; Key Laboratory […]
November 27, 2018

Blue-light based Cardiac rejuvenation therapy: Exposure to intense blue light suppresses tumor suppressor INK4a/p16 expression and inhibits dilated cardiomyopathy, via upregulation of its target gene, 27/November/2018, 10.28 am

What we say: Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: Blue-light based Cardiac rejuvenation therapy: Exposure to intense blue light suppresses tumor suppressor INK4a/p16 […]